Recent advances in targeted strategies for triple-negative breast cancer

Recent advances in targeted strategies for triple-negative breast cancer

Abstract Triple-negative breast cancer (TNBC), a highly aggressive subtype of breast cancer, negatively expresses estrogen receptor, progesterone receptor, and the human epidermal growth factor receptor 2 (HER2). Although chemotherapy is the main form of treatment for patients with TNBC, the effecti...

Full description

Bibliographic Details
Main Authors: Shuangli Zhu, Yuze Wu, Bin Song, Ming Yi, Yuheng Yan, Qi Mei, Kongming Wu
Format: Article
Language:English
Published: BMC 2023-08-01
Series:Journal of Hematology & Oncology
Subjects:
Triple-negative breast cancer
Molecular subtype
Targeted therapy
Immunotherapy
Online Access:https://doi.org/10.1186/s13045-023-01497-3

Internet

https://doi.org/10.1186/s13045-023-01497-3

Similar Items